Cargando…

Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV

Long-term delivery of anti-HIV monoclonal antibodies using adeno-associated virus (AAV) holds promise for the prevention and treatment of HIV infection. We previously reported that after receiving a single administration of AAV vector coding for anti-SIV antibody 5L7, monkey 84-05 achieved high leve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinez-Navio, José M., Fuchs, Sebastian P., Mendes, Desiree E., Rakasz, Eva G., Gao, Guangping, Lifson, Jeffrey D., Desrosiers, Ronald C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089924/ https://www.ncbi.nlm.nih.gov/pubmed/32256496 http://dx.doi.org/10.3389/fimmu.2020.00449

Ejemplares similares

Liver-Directed but Not Muscle-Directed AAV-Antibody Gene Transfer Limits Humoral Immune Responses in Rhesus Monkeys
por: Fuchs, Sebastian P., et al.
Publicado: (2019)

Glycoengineering of AAV-delivered monoclonal antibodies yields increased ADCC activity
por: Termini, James M., et al.
Publicado: (2020)

AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity
por: Fuchs, Sebastian P., et al.
Publicado: (2015)

High concordance of ELISA and neutralization assays allows for the detection of antibodies to individual AAV serotypes
por: Gardner, Matthew R., et al.
Publicado: (2022)

Recombinant AAV Vectors for Enhanced Expression of Authentic IgG
por: Fuchs, Sebastian P., et al.
Publicado: (2016)

Anti-drug Antibody Responses Impair Prophylaxis Mediated by AAV-Delivered HIV-1 Broadly Neutralizing Antibodies
por: Gardner, Matthew R., et al.
Publicado: (2019)

Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies
por: Fuchs, Sebastian P, et al.
Publicado: (2016)

Editorial: “AAV Gene Therapy: Immunology and Immunotherapeutics”
por: Martinez-Navio, José M., et al.
Publicado: (2021)

Induction of Transient Virus Replication Facilitates Antigen-Independent Isolation of SIV-Specific Monoclonal Antibodies
por: Pedreño-Lopez, Nuria, et al.
Publicado: (2020)

A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors
por: Davis-Gardner, Meredith E., et al.
Publicado: (2023)

Development of an anti-CAR antibody response in SIV-infected rhesus macaques treated with CD4-MBL CAR/CXCR5 T cells
por: Davey, Brianna C., et al.
Publicado: (2022)

Assessment of anti-CD20 antibody pre-treatment for augmentation of CAR-T cell therapy in SIV-infected rhesus macaques
por: Pampusch, Mary S., et al.
Publicado: (2023)

Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication
por: Haran, Kumudhini Preethi, et al.
Publicado: (2018)

Anti-AAV Antibodies in AAV Gene Therapy: Current Challenges and Possible Solutions
por: Weber, Thomas
Publicado: (2021)

SIV Vpx Is Essential for Macrophage Infection but Not for Development of AIDS
por: Westmoreland, Susan V., et al.
Publicado: (2014)

A recombinant herpesviral vector containing a near-full-length SIVmac239 genome produces SIV particles and elicits immune responses to all nine SIV gene products
por: Shin, Young C., et al.
Publicado: (2018)

Cervico-Vaginal Inflammatory Cytokine and Chemokine Responses to Two Different SIV Immunogens
por: Toledo, Nikki P. L., et al.
Publicado: (2020)

Induction of a virus-specific effector–memory CD4(+) T cell response by attenuated SIV infection
por: Gauduin, Marie-Claire, et al.
Publicado: (2006)

Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIV(mac251) acquisition in macaques
por: Rahman, Mohammad Arif, et al.
Publicado: (2023)

Persistent Low-Level Replication of SIVΔnef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV Infection
por: Adnan, Sama, et al.
Publicado: (2016)

ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIV(mac)251 Challenge
por: Alpert, Michael D., et al.
Publicado: (2012)

Cytotoxic Capacity of SIV-Specific CD8(+) T Cells against Primary Autologous Targets Correlates with Immune Control in SIV-Infected Rhesus Macaques
por: Mendoza, Daniel, et al.
Publicado: (2013)

Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge
por: Welles, Hugh C., et al.
Publicado: (2018)

Mapping the AAV Capsid Host Antibody Response toward the Development of Second Generation Gene Delivery Vectors
por: Tseng, Yu-Shan, et al.
Publicado: (2014)

Blood Transfusion Management for Patients Treated With Anti-CD38 Monoclonal Antibodies
por: Lancman, Guido, et al.
Publicado: (2018)

Generation and Characterization of Anti-AA Amyloid-Specific Monoclonal Antibodies
por: Wall, Jonathan S., et al.
Publicado: (2011)

Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention
por: Kisalu, Neville K., et al.
Publicado: (2021)

Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
por: Zhan, Wei, et al.
Publicado: (2021)

Early treatment with anti-α(4)β(7) antibody facilitates increased gut macrophage maturity in SIV-infected rhesus macaques
por: Johnson, Samuel D., et al.
Publicado: (2022)

Low levels of SIV-specific CD8+ T cells in germinal centers characterizes acute SIV infection
por: Li, Shengbin, et al.
Publicado: (2019)

Non-neutralizing Antibodies May Contribute to Suppression of SIVmac239 Viremia in Indian Rhesus Macaques
por: Pedreño-Lopez, Nuria, et al.
Publicado: (2021)

Innate and Adaptive Anti-SIV Responses in Macaque Semen: Implications for Infectivity and Risk of Transmission
por: Suphaphiphat, Karunasinee, et al.
Publicado: (2020)

T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021)

The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies
por: Vaisman-Mentesh, Anna, et al.
Publicado: (2020)

KIR3DL01 upregulation on gut natural killer cells in response to SIV infection of KIR- and MHC class I-defined rhesus macaques
por: Ries, Moritz, et al.
Publicado: (2017)

Neutralizing Monoclonal Antibodies to Fight HIV-1: On the Threshold of Success
por: Jaworski, Juan Pablo, et al.
Publicado: (2017)

KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors
por: Morales-Estevez, Cristina, et al.
Publicado: (2016)

New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are?
por: Basu, Biswanath, et al.
Publicado: (2022)

A humanized anti-human adenovirus 55 monoclonal antibody with good neutralization ability
por: Chen, Lei, et al.
Publicado: (2023)

Global CNS Gene Delivery and Evasion of Anti-AAV Neutralizing Antibodies by Intrathecal AAV Administration in Non-Human Primates
por: Gray, Steven J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nchsm9b06mceok52r0thl4tqmu